Phase 2 Central retinal vein occlusion Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Completed
Phase 2
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.
Central retinal vein occlusion
Salahuddin34 enrolled1 locationACTRN12622000267752
Recruiting
Phase 2
Bevacizumab intravitreal injection in the treatment of patients with Central Retinal Vein Occlusion.
Central retinal vein occlusion (CRVO)
Royal Adelaide Hospital22 enrolled1 locationACTRN12611000300976